Immunocore Holdings Ltd Dividends
The next dividend date for Immunocore Holdings Ltd has not yet been scheduled.
What is a Dividend Date
When we talk about a dividend date, we’re referring specifically to the ex-dividend date.
This is the date on which all stockholders will earn a dividend. Technically, a person needs to be the owner of a share of stock as of the night before the ex-dividend date in order to earn the dividend.
The ex-dividend date is different than the date when the dividend is issued. Although you earn a dividend on the ex-dividend date, that dividend is typically not disbursed to your account until several weeks later.
Most brokerages will automatically credit the dividend to your account once it’s issued.
Historical Dividends for Immunocore Holdings Ltd (IMCR)
More About Immunocore Holdings Ltd
Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including tebentafusp which is in Phase 3 clinical trial for the treatment of advanced cutaneous melanoma and adjuvant uveal melanoma; brenetafusp which is in Phase 3 clinical trial for the treatment of first-line advanced cutaneous melanoma and in Phase 1/2 clinical trial for the treatment of various tumor types; IMC-R117C which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, such as colorectal cancer; and IMC-P115C which is in Phase 1 clinical trial for patients with tumors that express PRAME. In addition, the company is involved in the development of IMC-M113V which is in Phase 1 clinical trial for a potential functional cure of human immunodeficiency virus; and IMC-I109V which is in Phase 1 clinical trial for a potential functional cure of hepatitis B virus. Further, it develops IMC-S118AI which is in pre-investigation stage for the treatment of type 1 diabetes; and IMC-U120AI which is in pre-investigation stage for the treatment of atopic dermatitis. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Owning Immunocore Holdings Ltd Stock on the Dividend Date
If you own Immunocore Holdings Ltd stock on the ex-dividend date, then you earn the associated dividend.
Theoretically, the price of Immunocore Holdings Ltd stock should go down by the amount of the dividend (in addition to any other pressures that market forces have on the price of Immunocore Holdings Ltd stock).
Therefore, it is typically not expected that there is any incremental profit to be gained from buying Immunocore Holdings Ltd stock right before the ex-dividend date and then selling it immediately after. It’s not like you get the Immunocore Holdings Ltd dividend payout for free just by doing that since there is typically an equivalent commensurate drop in the stock price.
Learning More Immunocore Holdings Ltd Dividends
You can contact us any time if you would like to ask questions about Immunocore Holdings Ltd dividends or anything else related to the stock market.